SuperMush raises $3M Series A led by NDude Labs to expand wellness products
US-based functional wellness brand SuperMush has raised $3 million in a Series A funding round led by NDude Labs, an investment firm with operations in India and the US. The funds will support product expansion, team growth, and retail presence as SuperMush scales its offerings across over 2,000 stores.
Editor, Lazyfounder

US-based functional wellness brand SuperMush has raised $3 million in a Series A funding round led by NDude Labs, an investment firm with operations in India and the US. The funds will support product expansion, team growth, and retail presence as SuperMush scales its offerings across over 2,000 stores.
30 SEC SUMMARY
- NDude Labs, an India and US-based investment firm, has led a $3 million Series A round for US wellness brand SuperMush.
- SuperMush, founded in 2022, produces functional wellness products like Lion’s Mane gummies and Shilajit.
- The funding will support product expansion, team growth, and retail presence in over 2,000 US stores, including Target and Sprouts.
- NDude Labs focuses on healthcare and wellness investments across India and the US.
TABLE OF CONTENTS
- NDude Labs leads $3 million Series A for SuperMush
- SuperMush’s growth and retail expansion
- NDude Labs’ investment focus
- Background
- What this means
- Key takeaways
- FAQ
- Sources
KEY HIGHLIGHTS
- NDude Labs led a $3 million Series A funding round for US-based wellness brand SuperMush.
- SuperMush was founded in 2022 and produces functional wellness products like Lion’s Mane gummies and Shilajit.
- The brand is available in over 2,000 US retail stores, including Target and Sprouts.
- Funds will be used to expand product offerings, strengthen the team, and grow customer support infrastructure.
NDude Labs leads $3 million Series A for SuperMush
According to Entrackr, NDude Labs, an investment firm with operations in India and the US, has led a $3 million Series A funding round for SuperMush, a US-based functional wellness brand. The funding aims to support the company’s product portfolio expansion, formulations, and team growth.
SuperMush’s growth and retail expansion
SuperMush, founded in 2022 by Alli Schaper and Brian Friedman, develops wellness products using ingredients such as nootropics, adaptogens, and functional mushrooms. Its portfolio includes products like Shilajit, Creatine, and Lion’s Mane gummies.
The brand has rapidly expanded its retail presence, now available in over 2,000 stores across the US, including major retailers like Target and Sprouts. Over the past year, SuperMush has entered more than 1,000 Target locations.
The fresh capital will enable SuperMush to further expand its retail, direct-to-consumer, and marketplace channels, including platforms like Amazon.
NDude Labs’ investment focus
NDude Labs invests in healthcare and wellness businesses across India and the US. The firm recently invested in Nutriventia, a nutraceutical ingredients company, reinforcing its commitment to the sector.
Background
The wellness and nutraceuticals industry has seen increased investor interest, particularly in functional products that leverage adaptogens and nootropics. SuperMush’s growth mirrors broader trends in consumer demand for health-focused supplements and functional foods.
Retail expansion remains a key strategy for direct-to-consumer brands seeking to scale. SuperMush’s presence in major retailers like Target and Sprouts highlights the importance of strategic partnerships in driving growth.
What this means
Lazyfounder analysis — our interpretation, not reported fact.
This funding round signals growing investor interest in functional wellness brands, particularly those leveraging adaptogens and nootropics. For founders, SuperMush’s rapid retail expansion—now in over 2,000 stores—demonstrates how niche health products can scale quickly with the right backing. The involvement of NDude Labs, a firm with footprints in both India and the US, also highlights the potential for cross-border investment in wellness startups. However, founders should note that scaling a product portfolio requires more than capital; it demands strong formulations, customer support, and strategic retail partnerships to sustain growth.
Key takeaways
- SuperMush has secured $3 million in Series A funding led by NDude Labs.
- The brand is expanding its product line and retail presence, including in major US stores like Target and Sprouts.
- NDude Labs is actively investing in healthcare and wellness startups across India and the US.
FAQ
What is SuperMush?
SuperMush is a US-based functional wellness brand founded in 2022. It produces products using ingredients like nootropics, adaptogens, and functional mushrooms, including Lion’s Mane gummies and Shilajit.
Who led the $3 million Series A funding round for SuperMush?
NDude Labs, an investment firm with operations in India and the US, led the $3 million Series A funding round for SuperMush.
How will SuperMush use the fresh capital?
The funds will be used to expand SuperMush’s product portfolio, invest in formulations, strengthen the team, and grow customer support infrastructure. The brand also plans to expand its retail and direct-to-consumer channels.
Where is SuperMush available?
SuperMush is available in over 2,000 US retail stores, including Target and Sprouts, as well as on marketplace platforms like Amazon.
Related on Lazyfounder
Sources
- Entrackr · 2026-10-06
India’s NDude Labs leads $3 Mn Series A in US wellness brand SuperMush
This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.
About the author
Editor, Lazyfounder
Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.
More stories by Tarun MottliaGet the LazyFounder Brief
Startup, funding and AI news in a five-minute read. Join the early-access list.


